Conagra Brands (CAG) Q1 2027 Prepared Remarks earnings summary

Executive summary

• Q1 fiscal 2027 delivered a solid start with net sales declining 1.4% to $2.6 billion and organic net sales down 1.1%, while profitability exceeded expectations and full-year guidance was reaffirmed.

• Adjusted EPS rose 5.1% to $0.41, and adjusted operating margin was 11.5%, reflecting progress on margin restoration and capital allocation priorities.

• Strategic focus included restoring margins, investing in brands and supply chain, reducing complexity, and rebalancing capital allocation.

• SG&A expenses increased due to legal, restructuring, and environmental charges, but adjusted SG&A benefited from lower incentive compensation.

Financial highlights

• Net sales were $2.6 billion, down 1.4% year-over-year; organic net sales declined 1.1%.

• Adjusted gross margin was 23.8% (down 62 bps); adjusted operating margin was 11.5% (down 33 bps); adjusted EBITDA grew 2.4% to $451 million.

• Adjusted EPS increased 5.1% to $0.41; net income rose 6.0% to $174.3 million.

• Free cash flow was ($128) million, impacted by litigation payments and restructuring charges.

• Net debt reduced by $193 million year-over-year to $7.4 billion; net leverage ratio at 3.99x.

Outlook and guidance

• Fiscal 2027 guidance reaffirmed: organic net sales expected to decline 1% to 3%, adjusted EPS between $1.40 and $1.50, and adjusted operating margin of 10.0%–10.5%.

• Q2 organic net sales expected to decline ~2%, with adjusted operating margin projected in the high single digits.

• Capital expenditures for fiscal 2027 estimated at $550 million; free cash flow conversion expected to exceed 90%.

• Key assumptions include equity earnings ~$140 million, pension income ~$25 million, interest expense ~$360 million, and adjusted tax rate ~24%.